Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital

Alessia Floerchinger1, Kendelle J Murphy1, Sharissa L Latham1

  • 1The Garvan Institute of Medical Research, St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW 2010, Australia.

Cell Reports
|September 15, 2021
PubMed

Insights

This study uses live imaging to show that inhibiting Rac1 activity in breast cancer cells can reduce their spread. This approach helps optimize cancer treatment and improve survival by impairing metastatic progression.

Area of Science:

  • Oncology
  • Cell Biology
  • Biomedical Imaging

Background:

  • Assessing drug response in native tissue is crucial for effective cancer therapy.
  • Understanding tumor cell behavior and movement is key to preventing metastasis.

Purpose of the Study:

  • To investigate the role of Rac1 activity in breast cancer metastasis using intravital imaging.
  • To guide treatment scheduling for improved anti-metastatic efficacy.

Main Methods:

  • Longitudinal intravital imaging of a Rac1-Förster resonance energy transfer (FRET) biosensor mouse.
  • In vivo photoswitching for tracking intratumoral cell movement.
  • Optical window imaging to observe tumor vasculature interactions.

Main Results:

  • Altered Rac1 activity was observed at the tumor center versus invasive borders.
  • Rac1 activity was enhanced in tumor cells near blood vessels.
  • Rac1 inhibition increased tumor cell vulnerability to shear stress, reducing metastasis.

Conclusions:

  • Single-cell intravital imaging is valuable for studying tumor progression in vivo.
  • Rac1 inhibition can reduce breast cancer metastasis and improve survival.
  • Targeting Rac1 offers a potential strategy for anti-metastatic therapy.

Related Concept Videos